Pharmaceuticals

Infanrix and Infanrix-hexa Market 2026 strengthening pediatric vaccination

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Infanrix And Infanrix-hexa Market From 2026 To 2030?

The expansion observed during the historical timeframe was primarily driven by the enlargement of standard immunization initiatives, an increased understanding of preventing infectious diseases in children, state-sponsored vaccination efforts, the presence of multi-component vaccine options, and the development of public health frameworks.

The projected growth during the forecast period is driven by several factors, such as increasing birth rates in developing economies, the expansion of global immunization access, a rise in investments towards vaccine manufacturing capabilities, an increasing emphasis on combination vaccines to alleviate the burden of multiple doses, and greater involvement from global health organizations. Significant trends anticipated within the same period include a growing uptake of combination pediatric vaccines, an escalating demand for hexavalent immunization initiatives, heightened attention to optimizing cold chain management, the expansion of national childhood vaccination schedules, and a reinforced focus on vaccine safety and regulatory compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20314&type=smp

What Major Drivers Are Influencing Demand In The Infanrix And Infanrix-hexa Market?

The rising prevalence of pertussis incidents is projected to stimulate growth in the Infanrix and Infanrix-hexa market. Pertussis cases refer to the documented occurrences of whooping cough, a highly infectious respiratory illness, during a specific period. The number of pertussis cases has been climbing due to decreased vaccination rates, shifts in immunity, and an increase in either undiagnosed or misdiagnosed instances. This surge in pertussis cases is driving up demand for Infanrix and Infanrix-hexa vaccines, as these are effective in preventing the highly contagious disease, leading to greater adoption and market expansion. For example, in October 2024, the Health Protection Surveillance Centre, an Ireland-based specialist agency for monitoring communicable diseases, reported around 514 pertussis cases in Ireland for 2024, marking a substantial increase from the 18 cases recorded in 2023. Therefore, the growing incidence of pertussis cases will fuel the expansion of the Infanrix and Infanrix Hexa vaccine market.

Which Segments Are Included In The Analysis Of The Infanrix And Infanrix-hexa Market?

The infanrix and infanrix-hexa market covered in this report is segmented –

1) By Patient Demographics: Infants, Children, Adolescents And Adults

2) By Clinical Indication: Diphtheria, Tetanus, Pertussis (Whooping Cough), Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type B (Hib)

3) By Distribution Channel: Hospitals, Clinics, Public Health Programs, Pharmacies

4) By Application: Primary Vaccination, Booster Doses, Combination With Other Vaccines

Which Key Industry Participants Are Active In The Infanrix And Infanrix-hexa Market?

Major companies operating in the infanrix and infanrix-hexa market are GlaxoSmithKline plc

Read the full infanrix and infanrix-hexa market report here:

https://www.thebusinessresearchcompany.com/report/infanrix-and-infanrix-hexa-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Infanrix And Infanrix-hexa Market?

North America was the largest region in the infanrix and infanrix-hexa market in 2025. The regions covered in the infanrix and infanrix-hexa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Infanrix And Infanrix-hexa Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20314&type=smp

Browse Through More Reports Similar to the Global Infanrix And Infanrix-hexa Market 2026, By The Business Research Company

Hexane Market Report 2026

https://www.thebusinessresearchcompany.com/report/hexane-global-market-report

Augmented Analytics In Banking Financial Services And Insurance Bfsi Market Report 2026

https://www.thebusinessresearchcompany.com/report/augmented-analytics-in-banking-financial-services-and-insurance-bfsi-global-market-report

Automotive Aftermarket Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-aftermarket-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795